POSA350 Effect of Filgotinib on EQ-5D-5L and Work Productivity and Activity Impairment Among Patients with Ulcerative Colitis: Results from the Phase 2B/3 Selection Trial
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.1061
https://www.valueinhealthjournal.com/article/S1098-3015(21)02856-4/fulltext
Title :
POSA350 Effect of Filgotinib on EQ-5D-5L and Work Productivity and Activity Impairment Among Patients with Ulcerative Colitis: Results from the Phase 2B/3 Selection Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02856-4&doi=10.1016/j.jval.2021.11.1061
First page :
Section Title :
Open access? :
No
Section Order :
10598